Non-invasive Intracranial Pressure Monitoring Device Market Size, Share & Trends Analysis Report By Type (MRI/CT, Optic Nerve Sheath Diameter), By Application, By Region, And Segment Forecasts, 2020 - 2027

Report Overview

The global non-invasive intracranial pressure monitoring device market size was valued at USD 252.31 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2020 to 2027. The rising incidence of neurological disorders and increasing road accidents, which result in traumatic brain injuries, are among the key factors fueling the growth of the market. In addition, rising demand for minimally invasive surgeries, the launch of new technologies, and the high demand for these devices in trauma care are few other factors contributing to the market growth. The escalating cases of neurological disorders, such as intracranial tumors, hydrocephalus, brain infection, aneurysm, and meningitis, as well as increasing incidence of trauma events due to road accidents, sports injuries, and falls worldwide are anticipated to fuel market growth.

For instance, according to the American Association for the Surgery of Trauma, around 1.2 million people died globally in 2017, amounting to around 3,242 deaths per day due to road accidents. These injuries or trauma result in elevated intracranial pressure, which, in turn, would increase the demand for ICP monitoring devices, thus affecting the growth of the market positively. Furthermore, meningitis (brain infection) infects the cerebrospinal fluid, which leads to a rise in intracranial pressure. For instance, as per the WHO 2018 report, around 30,000 cases of meningitis are reported every year from sub-Saharan Africa. These devices constantly monitor intracranial pressure and allow neurosurgeons for the early recognition of the disease and its timely treatment, thus affecting the growth of the market positively.

Moreover, the rising demand for minimally invasive surgical techniques due to enhanced patient outcomes is a high-impact rendering driver in this market. Due to the invasive nature, high cost, and other additional risks of standard ICP monitoring methods, alternative non-invasive techniques have been sought for the measurement of elevated ICP. It is not feasible to use invasive techniques in several conditions, such as emergencies, due to a lack of skilled professionals. Thus, non-invasive methods, such as optic nerve sheath diameter, transcranial doppler ultrasonography, and MRI/CT, are considered to be promising techniques to overcome these problems.

For instance, Vittamed 205, developed by Vittamed Corporation, and Cerepress, which is developed by Third Eye Diagnostics, are designed to measure and monitor ICP non-invasively via the eye. Similarly, MMS-14 developed by Marchbanks Measurement Systems and HS-1000M Monitor developed by HeadSense Medical, Ltd., use acoustic sound to measure and monitor the ICP non-invasively through ears. They are intended to be used in patients with stroke, traumatic brain injuries/concussions, hydrocephalus, neurological conditions, and other pathologies that may lead to intracranial hyper- and hypotension. Thus, various benefits associated with these procedures are contributing to market growth.

Furthermore, the development of technologically advanced ICP monitoring devices has reduced direct human interference in surgical procedures. These devices are lowering the drawbacks of earlier invasive-type devices, such as an impulsive shift in baseline pressure and leveling and de-bubbling linked with fluid-filled techniques. Some of the recent innovations include high-definition microscopic cameras, remote navigation systems, data recorders, motion sensors, and robotic-controlled catheters and transducers. Key market players are involved in extensive research and development activities to develop technologically advanced devices. For instance, in November 2016, Medtronic signed an agreement with University Hospitals. Under this agreement, they will work together to improve the operational efficiency and workflow of various procedures, including electrophysiology and catheterization. This is expected to boost market growth during the forecast period.

Countries such as the U.S. and Canada have witnessed a high prevalence rate of neurological disorders and trauma cases. For instance, according to the report published by the American Association for the Surgery of Trauma in 2020, trauma is one of the leading causes of death in the U.S. for individuals aged up to 45. In addition, the presence of technologically advanced healthcare infrastructure and increasing patient awareness regarding the benefits associated with minimally invasive surgeries are among the major factors contributing to market growth. Furthermore, a rise in the number of road accidents is anticipated to boost the demand for intracranial pressure monitoring devices. For instance, according to the report by the Brain Injury Association of Waterloo-Wellington (BIAWW), over 11,000 individuals die due to brain-related injuries in Canada every year and more than 6,000 become permanently disabled post injuries. This is anticipated to boost the market growth over the forecast period.

Furthermore, the global geriatric population is increasing at a high rate. According to the UN Department of Economic and Social Affairs, currently, the global population is 7.7 billion, which is expected to increase to 9.7 billion by 2050. The geriatric population is prone to various neurological conditions as well as traumatic brain injuries. Thus, the increasing geriatric population worldwide is expected to be a high-impact rendering driver for the market during the forecast period. Moreover, the high geriatric population in Asian countries, such as Japan and China, presents a number of untapped opportunities, thereby boosting the market growth during the forecast period. As per estimates, more than 20% of the population in Japan is over the age of 65 years. According to a report by the WHO, fall-related injuries in the elderly are a major health and social concern in China, with approximately 18% to 44% of the elderly people reporting falls.

Type Insights

Based on type, the market is segmented into transcranial doppler ultrasonography, tympanic membrane displacement (TMD), optic nerve sheath diameter, MRI/CT, and fundoscopy (papilledema). The MRI/CT segment dominated the market with a share of 28.34% in 2019. These devices help to get results faster and safely as well as they are easy to use and provide excellent images with high contrast between pathologic and normal tissues. Moreover, MRI/CT scans are the widely preferred imaging devices owing to their higher sensitivity to assess patients with traumatic brain injuries with elevated ICPs. Thus, increasing applications in the diagnosis and staging of neurological diseases as well as its advantages over other imaging modalities have fueled the growth of this segment.

The optic nerve sheath diameter segment is expected to register the highest CAGR of 6.9% from 2020 to 2027 as it is the most appropriate and widely preferred modality for emergency medical situations, such as severe head trauma, hydrocephalus, and intracranial hemorrhage. Moreover, increasing patient preference for non-invasive procedures and high preference among physicians are expected to drive the segment.

Application Insights

Based on the application, the market is segmented into traumatic brain injury, subarachnoid hemorrhage, meningitis, intracerebral hemorrhage, and others. The traumatic brain injury segment dominated the market with a share of 46.73% in 2019 owing to the increasing prevalence of traumatic brain injuries due to road accidents, falls, and violence. According to the CDC, the number of traumatic brain injuries has significantly increased in the past few years. Elevated ICP is the most common cause of mortality in patients suffering from traumatic brain injuries. The success of the treatment is largely based on the accurate assessment of ICP. Thus, non-invasive intracranial pressure monitoring devices help in keeping the pressure levels in the normal range to optimize cerebral perfusion pressure. This is expected to fuel the segment growth during the forecast period.

The others segment, which includes brain edema, hydrocephalus, and CNS infection, is expected to register the highest CAGR of 7.0% from 2020 to 2027. For instance, according to the 2018 report by the Hydrocephalus Association, around 1 million people are suffering from hydrocephalus in the U.S., and it is the most common reason for raised ICP. Additionally, brain edema results in elevated intracranial pressure, which involves precise measurement for early and effective treatment. Therefore, a major portion of the global population is suffering from CNS infection, hydrocephalus, or brain edema, which depends on ICP measurement for timely and safe treatment of such conditions.

Regional Insights

North America dominated the market with a share of 46.78% in 2019. This is attributed to the high prevalence of neurological disorders as well as an increasing number of trauma cases, thus leading to elevated intracranial pressure. These factors are expected to increase the application of non-invasive intracranial pressure monitoring devices in this region, thereby positively impacting the growth of the market. Furthermore, supportive government initiatives, including the establishment of the American Society of Craniofacial Surgery (ASCFS), for creating awareness about minimally invasive Craniomaxillofacial (CMF) surgeries, are expected to propel the market growth during the forecast period. Thus, the increasing prevalence of neurological disorders and growing awareness among individuals about minimally invasive surgeries are driving the regional market.

Asia Pacific is expected to expand at the highest CAGR of 7.3% from 2020 to 2027. This is attributed to the presence of a large patient base in the emerging economies, such as India and China, along with rising healthcare expenditures in this region. Moreover, an increase in the number of clinical trials and high R&D investments by global market players owing to low-cost services in the region are high impact rendering drivers in the market. In addition, the increasing incidence of road accidents and neurological diseases is aiding the market growth in this region. According to the WHO Global Report on Road Safety 2018, around 11% of the road accident-associated deaths in the world are reported from India. Approximately, 4,67,044 road accidents were reported in the year 2018. This is anticipated to impel market growth over the forecast period.

Key Companies & Market Share Insights

Key market players account for a considerable share in the market owing to their broad product offerings. Market leaders are involved in extensive research for the development of advanced technologies. For instance, in April 2017, Medtronic launched its StealthStation technology at the AANS conference held in Los Angeles. The new model is designed to enhance the workflow of neurosurgeries and is expected to replace its previous versions.

Furthermore, various companies are undergoing collaborations and partnerships aiming to expand their product portfolio, increase the reach of their offerings, and provide competitive diversity. For instance, in January 2019, Medtronic completed the acquisition of Israel-based Mazor Robotics and its robot-assisted surgery platform for USD 1.7 billion. Through this acquisition, Mazor Robotics will integrate within Medtronic’s Neurosurgery business and bolster the company’s market position in spine surgery. Similarly, in July 2019, Integra LifeSciences acquired Arkis Biosciences Inc., a neurosurgical device company. This purchase will boost Integra’s product offerings in neurocritical care. Such initiatives are expected to improve the company’s revenue and its worldwide presence in the forthcoming years. Some prominent players in the global non-invasive intracranial pressure monitoring device market include:

• Codman Neuro (Integra LifeSciences)

• Medtronic

• RAUMEDIC AG

• SOPHYSA

• Spiegelberg GmbH & Co. KG

• Natus Medical Incorporated

• Gaeltec Devices Ltd.

• Neural Analytics

Non-invasive Intracranial Pressure Monitoring Device Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global non-invasive intracranial pressure monitoring device market report on the basis of type, application, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2027)

  • Transcranial Doppler Ultrasonography

  • Tympanic Membrane Displacement (TMD)

  • Optic Nerve Sheath Diameter

  • MRI/CT

  • Fundoscopy (Papilledema)

• Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Traumatic Brain Injury

  • Intracerebral Hemorrhage

  • Meningitis

  • Subarachnoid Hemorrhage

  • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE